Details of issuance or disposal
14th Stock Acquisition Rights issued through a third-party allotment (with provisions for adjustment of the exercise price)
Shares delivered during the month under review: 3,435,000 shares (new shares). Transfer of treasury shares: Not stated (shown as "-") in the table
The lower thin line represents the existing number of shares to which these shares will be added.
3,435,000 shares delivered during the month under review. Approximately 3.13% of the number of issued shares of 109,829,569 at the end of the month preceding the month under review (the document does not state this as a dilution rate)
The dilution rate shows what proportion the newly issued shares represent of the existing shares. The higher the proportion, the more the value and voting rights per share are diluted.
| Item | Details |
|---|---|
| Type of issuance or disposal | 14th Stock Acquisition Rights issued through a third-party allotment (with provisions for adjustment of the exercise price) |
| Number of shares to be issued or disposed of | Shares delivered during the month under review: 3,435,000 shares (new shares). Transfer of treasury shares: Not stated (shown as "-") in the table |
| Intended allottee | Nagasawa Makoto (長澤 誠), the allottee at the time of issuance on 15 December 2023. The allottee for the exercises during the month is not stated |
| Dilution Rate | 3,435,000 shares delivered during the month under review. Approximately 3.13% of the number of issued shares of 109,829,569 at the end of the month preceding the month under review (the document does not state this as a dilution rate) |
| Total number of issued shares | 109,829,569 shares (as of the end of the month preceding the month under review) → 113,264,569 shares (assuming the shares delivered during the month under review are simply added) |
| Exercise price | ¥38.0. An Exercise Price Adjustment Clause applies. The minimum exercise price is not stated in this document |
| Number of Stock Acquisition Rights | Total issued: 187,000 rights. Unexercised balance at the end of the month preceding the month under review: 67,500 rights; unexercised balance at month-end: 33,150 rights |
| Most recent equity financing | Timing 15 December 2023 / Type Issuance of the 14th Series of Stock Acquisition Rights (with exercise price adjustment clause) / Amount Not disclosed |
Items this document does not state (20)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To report the monthly exercise status. The purpose of the funds and the reasons for exercise are not stated in this document.